Is doxepin in the same drug class as Adarax (loratadine)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 9, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Are Doxepin and Adarax (Loratadine) in the Same Drug Class?

No, doxepin and loratadine (Adarax) are not in the same drug class. Doxepin is a tricyclic antidepressant with potent antihistamine properties, while loratadine is a second-generation non-sedating antihistamine. 1, 2

Drug Classification

Doxepin

  • Primary class: Tricyclic antidepressant (TCA) 3, 1
  • Chemical structure: Closely related to other TCAs such as amitriptyline and imipramine 1
  • Mechanism: At therapeutic antidepressant doses (typically 75-300 mg/day), it functions as a TCA with mood-elevating and sedative effects 1
  • At low doses (1-6 mg): Functions primarily as a potent H1-histamine receptor antagonist with unique selectivity for this receptor 4
  • Additional properties: Also possesses H2-blocking activity, which distinguishes it from conventional antihistamines 5

Loratadine (Adarax)

  • Primary class: Second-generation non-sedating antihistamine 2
  • Chemical structure: Related to tricyclic antidepressants structurally, but functions entirely differently 2
  • Mechanism: Selective peripheral H1-receptor antagonist with threefold greater affinity for peripheral versus central histamine receptors 2
  • Key characteristic: Minimal CNS penetration, resulting in non-sedating properties 2

Clinical Distinctions

Sedation Profile

  • Doxepin: Causes significant sedation even at low doses due to CNS penetration; this is a primary therapeutic effect when used for insomnia 3, 4
  • Loratadine: Produces sedation no more frequently than placebo due to minimal brain penetration 2

Duration and Dosing

  • Doxepin: Typically dosed 10 mg three times daily for pruritus, or 1-6 mg once nightly for insomnia 3, 5
  • Loratadine: Once-daily dosing with onset within 1 hour and duration of at least 24 hours 2

Therapeutic Applications

  • Doxepin: Used for depression (at high doses), insomnia (at low doses 1-6 mg), chronic urticaria refractory to conventional antihistamines, and pruritus associated with various conditions 3, 6, 5
  • Loratadine: Used for allergic rhinitis, urticaria, and acute allergic reactions 3, 2

Important Clinical Caveats

When Doxepin May Be Preferred Over Conventional Antihistamines

  • Chronic urticaria poorly responsive to standard antihistamines: Doxepin 10 mg three times daily shows complete response in 44% and overall response in 75% of refractory cases 6
  • The superior efficacy may be due to combined H1 and H2 blocking properties that conventional antihistamines lack 5

Safety Considerations

  • Doxepin carries TCA-related risks: Including cardiotoxicity on overdose, anticholinergic effects (dry mouth, constipation), and potential for drug interactions as a sodium channel blocker 3, 1
  • Topical doxepin: Should be limited to 8 days, 10% of body surface area, and 12 g daily due to systemic absorption and sedation risk 3
  • Loratadine: Has minimal adverse effects comparable to placebo, with no significant drug interaction potential 2

Common Pitfall

Do not assume that because loratadine is "chemically related to tricyclic antidepressants" 2 that it shares their pharmacologic class or clinical properties—the structural similarity does not translate to functional similarity, as loratadine lacks antidepressant, anticholinergic, and sodium channel blocking effects.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.